A detailed history of Headinvest, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Headinvest, LLC holds 12,529 shares of ABT stock, worth $1.28 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
12,529
Previous 12,710 1.42%
Holding current value
$1.28 Million
Previous $1.23 Million 12.11%
% of portfolio
0.29%
Previous 0.27%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $16,324 - $19,982
-181 Reduced 1.42%
12,529 $1.38 Million
Q3 2023

Dec 11, 2023

BUY
$95.53 - $114.62 $7,737 - $9,284
81 Added 0.64%
12,710 $1.23 Million
Q2 2023

Aug 23, 2023

SELL
$100.78 - $112.29 $78,709 - $87,698
-781 Reduced 5.82%
12,629 $1.38 Million
Q1 2023

May 17, 2023

BUY
$96.86 - $114.01 $3,777 - $4,446
39 Added 0.29%
13,410 $1.36 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $1,711 - $2,007
18 Added 0.13%
13,371 $1.47 Million
Q3 2022

Dec 28, 2022

BUY
$96.76 - $112.03 $34,446 - $39,882
356 Added 2.74%
13,353 $1.29 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $34,295 - $41,452
336 Added 2.65%
12,997 $1.41 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $33,977 - $41,433
298 Added 2.41%
12,661 $1.5 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $28,304 - $34,657
245 Added 2.02%
12,363 $1.74 Million
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $7,232 - $8,001
62 Added 0.51%
12,118 $1.43 Million
Q2 2021

Aug 30, 2021

BUY
$105.79 - $124.53 $14,281 - $16,811
135 Added 1.13%
12,056 $1.4 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $68,678 - $80,913
-631 Reduced 5.03%
11,921 $1.43 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $41,580 - $45,310
-396 Reduced 3.15%
12,156 $1.33 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $41,580 - $45,310
396 Added 3.26%
12,552 $1.37 Million
Q3 2020

Nov 24, 2020

SELL
$91.64 - $111.29 $916 - $1,112
-10 Reduced 0.08%
12,552 $1.37 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $2,373 - $3,038
31 Added 0.25%
12,562 $1.15 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $67,217 - $98,290
1,070 Added 9.34%
12,531 $989,000
Q1 2020

May 11, 2020

SELL
$62.82 - $91.86 $89,204 - $130,441
-1,420 Reduced 11.02%
11,461 $904,000
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $2,904 - $3,233
-37 Reduced 0.29%
12,881 $1.12 Million
Q3 2019

Nov 21, 2019

BUY
$81.84 - $88.74 $93,461 - $101,341
1,142 Added 9.7%
12,918 $1.08 Million
Q2 2019

Aug 22, 2019

BUY
$72.88 - $85.0 $22,957 - $26,775
315 Added 2.75%
11,776 $990,000
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $759,013 - $917,647
-11,462 Reduced 50.0%
11,461 $916,000
Q4 2018

Feb 22, 2019

BUY
$65.56 - $74.27 $758,857 - $859,675
11,575 Added 102.0%
22,923 $1.66 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $18,243 - $22,008
-300 Reduced 2.58%
11,348 $833,000
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $5,008 - $5,527
87 Added 0.75%
11,648 $710,000
Q4 2017

Jan 30, 2018

SELL
$53.68 - $57.47 $46,164 - $49,424
-860 Reduced 6.92%
11,561 $660,000
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $596,953 - $666,262
12,421
12,421 $674,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Headinvest, LLC Portfolio

Follow Headinvest, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.